Bone marrow-derived stem cell transplantation for the treatment of insulin-dependent diabetes.

Carmen Fotino, Camillo Ricordi, Vincenzo Lauriola, Rodolfo Alejandro, Antonello Pileggi

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

The bone marrow is an invaluable source of adult pluripotent stem cells, as it gives rise to hematopoietic stem cells, endothelial progenitor cells, and mesenchymal cells, amongst others. The use of bone marrow-derived stem cell (BMC) transplantation (BMT) may be of assistance in achieving tissue repair and regeneration, as well as in modulating immune responses in the context of autoimmunity and transplantation. Ongoing clinical trials are evaluating the effects of BMC to preserve functional beta-cell mass in subjects with type 1 and type 2 diabetes, and to favor engraftment and survival of transplanted islets. Additional trials are evaluating the impact of BMT (i.e., mesenchymal stem cells) on the progression of diabetes complications. This article reviews the progress in the field of BMC for the treatment of subjects with insulin-dependent diabetes, and summarizes clinical data of pilot studies performed over the last two decades at our research center by combining allogeneic islet transplantation with donor-specific BMC. Clinical data is summarized from pilot studies performed at our research center over the last two decades.

Original languageEnglish
Pages (from-to)144-157
Number of pages14
JournalThe review of diabetic studies : RDS
Volume7
Issue number2
StatePublished - Jun 1 2010
Externally publishedYes

Fingerprint

Stem Cell Transplantation
Bone Marrow
Insulin
Stem Cells
Mesenchymal Stem Cell Transplantation
Therapeutics
Islets of Langerhans Transplantation
Pluripotent Stem Cells
Adult Stem Cells
Homologous Transplantation
Diabetes Complications
Hematopoietic Stem Cells
Autoimmunity
Type 1 Diabetes Mellitus
Research
Type 2 Diabetes Mellitus
Regeneration
Transplantation
Clinical Trials

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Bone marrow-derived stem cell transplantation for the treatment of insulin-dependent diabetes. / Fotino, Carmen; Ricordi, Camillo; Lauriola, Vincenzo; Alejandro, Rodolfo; Pileggi, Antonello.

In: The review of diabetic studies : RDS, Vol. 7, No. 2, 01.06.2010, p. 144-157.

Research output: Contribution to journalArticle

@article{b61be42e8cb148859a3137e59a37006b,
title = "Bone marrow-derived stem cell transplantation for the treatment of insulin-dependent diabetes.",
abstract = "The bone marrow is an invaluable source of adult pluripotent stem cells, as it gives rise to hematopoietic stem cells, endothelial progenitor cells, and mesenchymal cells, amongst others. The use of bone marrow-derived stem cell (BMC) transplantation (BMT) may be of assistance in achieving tissue repair and regeneration, as well as in modulating immune responses in the context of autoimmunity and transplantation. Ongoing clinical trials are evaluating the effects of BMC to preserve functional beta-cell mass in subjects with type 1 and type 2 diabetes, and to favor engraftment and survival of transplanted islets. Additional trials are evaluating the impact of BMT (i.e., mesenchymal stem cells) on the progression of diabetes complications. This article reviews the progress in the field of BMC for the treatment of subjects with insulin-dependent diabetes, and summarizes clinical data of pilot studies performed over the last two decades at our research center by combining allogeneic islet transplantation with donor-specific BMC. Clinical data is summarized from pilot studies performed at our research center over the last two decades.",
author = "Carmen Fotino and Camillo Ricordi and Vincenzo Lauriola and Rodolfo Alejandro and Antonello Pileggi",
year = "2010",
month = "6",
day = "1",
language = "English",
volume = "7",
pages = "144--157",
journal = "The review of diabetic studies : RDS",
issn = "1613-6071",
publisher = "Society for Biomedical Diabetes Research",
number = "2",

}

TY - JOUR

T1 - Bone marrow-derived stem cell transplantation for the treatment of insulin-dependent diabetes.

AU - Fotino, Carmen

AU - Ricordi, Camillo

AU - Lauriola, Vincenzo

AU - Alejandro, Rodolfo

AU - Pileggi, Antonello

PY - 2010/6/1

Y1 - 2010/6/1

N2 - The bone marrow is an invaluable source of adult pluripotent stem cells, as it gives rise to hematopoietic stem cells, endothelial progenitor cells, and mesenchymal cells, amongst others. The use of bone marrow-derived stem cell (BMC) transplantation (BMT) may be of assistance in achieving tissue repair and regeneration, as well as in modulating immune responses in the context of autoimmunity and transplantation. Ongoing clinical trials are evaluating the effects of BMC to preserve functional beta-cell mass in subjects with type 1 and type 2 diabetes, and to favor engraftment and survival of transplanted islets. Additional trials are evaluating the impact of BMT (i.e., mesenchymal stem cells) on the progression of diabetes complications. This article reviews the progress in the field of BMC for the treatment of subjects with insulin-dependent diabetes, and summarizes clinical data of pilot studies performed over the last two decades at our research center by combining allogeneic islet transplantation with donor-specific BMC. Clinical data is summarized from pilot studies performed at our research center over the last two decades.

AB - The bone marrow is an invaluable source of adult pluripotent stem cells, as it gives rise to hematopoietic stem cells, endothelial progenitor cells, and mesenchymal cells, amongst others. The use of bone marrow-derived stem cell (BMC) transplantation (BMT) may be of assistance in achieving tissue repair and regeneration, as well as in modulating immune responses in the context of autoimmunity and transplantation. Ongoing clinical trials are evaluating the effects of BMC to preserve functional beta-cell mass in subjects with type 1 and type 2 diabetes, and to favor engraftment and survival of transplanted islets. Additional trials are evaluating the impact of BMT (i.e., mesenchymal stem cells) on the progression of diabetes complications. This article reviews the progress in the field of BMC for the treatment of subjects with insulin-dependent diabetes, and summarizes clinical data of pilot studies performed over the last two decades at our research center by combining allogeneic islet transplantation with donor-specific BMC. Clinical data is summarized from pilot studies performed at our research center over the last two decades.

UR - http://www.scopus.com/inward/record.url?scp=79952278457&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952278457&partnerID=8YFLogxK

M3 - Article

C2 - 21060973

AN - SCOPUS:79952278457

VL - 7

SP - 144

EP - 157

JO - The review of diabetic studies : RDS

JF - The review of diabetic studies : RDS

SN - 1613-6071

IS - 2

ER -